{10} Ibid.

{11} Centre international de recherche sur le cancer, Evaluations globales de la canc'erog'enicit'e pour l’Homme. Disponible sur:iarc.fr/FR/Classification/crthall.php (consult'e le 07/03/2010).

{12} DGS, R'esultats du contr^ole sanitaire de la qualit'e de l’eau potable, 2009. Disponible sur:(consult'e le 17 mars 2010).

{13} Ibid.

{14} Institut national du cancer, Alcool et risque de cancer, 2007. Disponible sur:alcoolisme (consult'e le 17 mars 2010).

{15} Haut Conseil du minist`ere de la Sant'e, Avis relatif aux recommandations sanitaires en mati`ere de consommation d’alcool, 2009. Disponible sur:(consult'e le 17 mars 2010).

{16} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{17} Ibid.

{18} Fakhry C., Gillison M. L., «Clinical implications of human papillomavirus in head and neck cancers», J. Clin. Oncol., 2006, 24 (17), p. 2606–2611.

{19} World Cancer Research Fund, Food, Nutrition, Physical Activity, and the Prevention of Cancer: a Global Perspective, op. cit.

{20} Ibid.

{21} Ibid.

{22} Haut Conseil du minist`ere de la Sant'e, Avis relatif aux recommandations sanitaires en mati`ere de consommation d’alcool, op.cit.

{23} Sun W., Wang W., Kim J., Keng P., Yang S., Zhang H., Liu C., Okunieff P., Zhang L., «Anticancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignent», Adv. Exp. Med. Biol., 2008, 614, p. 179–186.

{24} Aprifel, R^ole b'en'efique des polyph'enols et du resv'eratrol du vin, 2001. Disponible sur:php?m=3&rub=54&a =769 (consult'e le 17 mars 2010).

{25} Adrian et al., Am. J. Enol. Viti c., 2000, 51, p. 37–41.

{26} Renaud S., Lorgeril M. de, «Wine, alcohol, platelets, and the French paradox for coronary heart disease», Lancet, 1992, 339 (8808), p. 1523–1526.

{27} Brisdelli F., D’Andrea G., Bozzi A., «Resveratrol: A natural polyphenol with multiple chemopreventive properties», Curr. Drug Metab., 2009, 10 (6), p. 530–546.

{28} Athar M., Back J. H., Kopelovich L., Bickers D. R., Kim A. L., «Multiple molecular targets of resveratrol: Anti-carcinogenic mechanisms», Arch. Biochem. Biophys., 2009, 486 (2), p. 95—102.

{29} Yusuf N., Nasti T. H., Meleth S., «Elmets CA. Resveratrol enhances cellmediated immune response to DMBA through TLR4 and prevents DMBA induced cutaneous carcinogenesis», Mol. Carcinog., 2009, 48 (8), p. 713–723.

{30} Seeni A., Takahashi S., Takeshita K., Tang M., Sugiura S., Sato S. Y., Shirai T., «Suppression of prostate cancer growth by resveratrol in the transgenic rat for adenocarcinoma of prostate (TRAP) model», Asian Pac. J. Cancer Prev., 2008, 9 (1), p. 7—14.

{31} Sengottuvelan M., Deeptha K., Nalini N., «Influence of dietary resveratrol on early and late molecular markers of 1,2-dimethylhydrazineinduced colon carcinogenesis», Nutrition, 2009, 25 (11–12), p. 1169–1176.

{32} Ding X. Z., Adrian T. E., «Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells», Pancreas, 2002, 25 (4), p. 71–76.

{33} Woodall C. E., Li Y., Liu Q. H., Wo J., Martin R. C., «Chemoprevention of metaplasia initiation and carcinogenic progression to esophageal adenocarcinoma by resveratrol supplementation», Anticancer Drugs, 2009, 20 (6), p. 437–443.

{34} AFSSA, «Table CIQUAL 2008», op. cit.

{35} Direction g'en'erale de la Sant'e, Cancer de la peau. M'elanome, 2003. Disponible sur:peau.pdf (consult'e le 18 mars 2010).

{36} AFSSET, FAQ Rayonnement ultraviolet. Disponible sur: http:// www.afsset.fr/index.php?pageid=634 & parentid=265&ongletlstid=427 (consult'e le 17 mars 2010).

{37} Sayre R. M., Dowdy J. C., «The increase in melanoma: are dietary furocoumarins responsable?», Med Hypotheses, 2008, 70 (4), p. 855–859.

{38} Feskanich D., Willett W. C., Hunter D. J., Colditz G. A., «Dietary intakes of vitamins A, C, and E and risk of melanoma in two cohorts of women», Br. J. Cancer, 2003, 88 (9), p. 1381–1387.

{39} Malik A., Afaq F., Sarfaraz S., Adhami V. M., Syed D. N., Mukhtar H., «Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer», Proc. Natl. Acad. Sci., 2005, 102 (41), p. 14813—14818.

{40} Pantuck A. J., Leppert J. T., Zomorodian N., Aronson W., Hong J., Barnard R. J., Seeram N., Liker H., Wang H., Elashoff R., Heber D., Aviram M., Ignarro L., Belldegrun A., «Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer», Clin. Cancer Res., 2006, 12 (13), p. 4018–4026.